{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:14:37Z","timestamp":1789967677003,"version":"4.0.1"},"reference-count":139,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["seminperinat.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1053\/j.semperi.2015.03.006","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T06:00:20Z","timestamp":1431496820000},"page":"217-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Newborn screening for spinal muscular atrophy: Anticipating an imminent need"],"prefix":"10.1053","volume":"39","author":[{"given":"Han C.","family":"Phan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Hannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6266","key":"10.1053\/j.semperi.2015.03.006_bib1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/344540a0","article-title":"Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2\u201313.3","volume":"344","author":"Brzustowicz","year":"1990","journal-title":"Nature"},{"issue":"2","key":"10.1053\/j.semperi.2015.03.006_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1373\/clinchem.2014.231019","article-title":"Newborn bloodspot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency","volume":"61","author":"Taylor","year":"2015","journal-title":"Clin Chem"},{"issue":"6","key":"10.1053\/j.semperi.2015.03.006_bib3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1373\/clinchem.2012.183038","article-title":"Newborn screening for spinal muscular atrophy by calibrated short-amplicon melt profiling","volume":"58","author":"Dobrowolski","year":"2012","journal-title":"Clin Chem"},{"issue":"1","key":"10.1053\/j.semperi.2015.03.006_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ogc.2010.03.001","article-title":"Spinal muscular atrophy: newborn and carrier screening","volume":"37","author":"Prior","year":"2010","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"7","key":"10.1053\/j.semperi.2015.03.006_bib5","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/ajmg.a.33474","article-title":"Newborn and carrier screening for spinal muscular atrophy","volume":"152a","author":"Prior","year":"2010","journal-title":"Am J Med Genet A"},{"issue":"11","key":"10.1053\/j.semperi.2015.03.006_bib6","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1373\/clinchem.2007.092312","article-title":"Assessment of liquid microbead arrays for the screening of newborns for spinal muscular atrophy","volume":"53","author":"Pyatt","year":"2007","journal-title":"Clin Chem"},{"issue":"7","key":"10.1053\/j.semperi.2015.03.006_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.gim.0000227970.60450.b2","article-title":"A feasibility study for the newborn screening of spinal muscular atrophy","volume":"8","author":"Pyatt","year":"2006","journal-title":"Genet Med"},{"issue":"5","key":"10.1053\/j.semperi.2015.03.006_bib8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/ahg.12031","article-title":"Spinal muscular atrophy: from gene discovery to clinical trials","volume":"77","author":"Nurputra","year":"2013","journal-title":"Ann Hum Genet"},{"issue":"9","key":"10.1053\/j.semperi.2015.03.006_bib9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jmg.2009.066969","article-title":"Differences in SMN1 allele frequencies among ethnic groups within North America","volume":"46","author":"Hendrickson","year":"2009","journal-title":"J Med Genet"},{"issue":"3","key":"10.1053\/j.semperi.2015.03.006_bib10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archneur.1971.00490030102014","article-title":"Two early infantile hereditary cases of progressive muscular atrophy simulating dystrophy, but on a neural basis. 1891","volume":"25","author":"Werdnig","year":"1971","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1053\/j.semperi.2015.03.006_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-2008-1040858","article-title":"Spinal muscular atrophy","volume":"18","author":"Iannaccone","year":"1998","journal-title":"Semin Neurol"},{"issue":"6278","key":"10.1053\/j.semperi.2015.03.006_bib12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/345823a0","article-title":"Genetic homogeneity between acute and chronic forms of spinal muscular atrophy","volume":"345","author":"Gilliam","year":"1990","journal-title":"Nature"},{"issue":"1","key":"10.1053\/j.semperi.2015.03.006_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1053\/j.semperi.2015.03.006_bib14","unstructured":"Safety and Efficacy of Olesoxime. \u3008https:\/\/clinicaltrials.gov\/ct2\/wshow\/NCT01302600?term=olesoxime+and+sma&rank=1\u3009. Accessed 01.09.15."},{"key":"10.1053\/j.semperi.2015.03.006_bib15","unstructured":"Self-Complementary AAV9. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02122952?term=sma&rank=39\u3009. Accessed 01.09.15."},{"key":"10.1053\/j.semperi.2015.03.006_bib16","unstructured":"Clinical Efficacy and Safety of ISIS 396443. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02193074?term=sma&rank=26\u3009. Accessed 01.09.15."},{"key":"10.1053\/j.semperi.2015.03.006_bib17","unstructured":"Pharmacodynamics of RO6885247. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02240355?term=sma&rank=51\u3009. Accessed 01.09.15."},{"issue":"1","key":"10.1053\/j.semperi.2015.03.006_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0960-8966(94)00075-K","article-title":"Chaos in the classification of SMA: a possible resolution","volume":"5","author":"Dubowitz","year":"1995","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1053\/j.semperi.2015.03.006_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.24497","article-title":"Spinal muscular atrophy: diagnosis and management in a new therapeutic era","volume":"51","author":"Arnold","year":"2015","journal-title":"Muscle Nerve"},{"issue":"8174","key":"10.1053\/j.semperi.2015.03.006_bib20","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(80)90847-8","article-title":"Classification of spinal muscular atrophies","volume":"1","author":"Pearn","year":"1980","journal-title":"Lancet"},{"issue":"5\u20136","key":"10.1053\/j.semperi.2015.03.006_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0960-8966(94)90090-6","article-title":"The natural history of type I (severe) spinal muscular atrophy","volume":"4","author":"Thomas","year":"1994","journal-title":"Neuromuscul Disord"},{"issue":"5\u20136","key":"10.1053\/j.semperi.2015.03.006_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0960-8966(94)90094-9","article-title":"The natural history of severe spinal muscular atrophy\u2014further evidence for clinical subtypes","volume":"4","author":"Ignatius","year":"1994","journal-title":"Neuromuscul Disord"},{"issue":"5\u20136","key":"10.1053\/j.semperi.2015.03.006_bib23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0960-8966(06)80008-8","article-title":"Cognitive functions in Duchenne muscular dystrophy: a reappraisal and comparison with spinal muscular atrophy","volume":"2","author":"Billard","year":"1992","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1053\/j.semperi.2015.03.006_bib24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0960-8966(01)00274-7","article-title":"Intelligence and cognitive function in children and adolescents with spinal muscular atrophy","volume":"12","author":"von Gontard","year":"2002","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1053\/j.semperi.2015.03.006_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","article-title":"The neurobiology of childhood spinal muscular atrophy","volume":"3","author":"Crawford","year":"1996","journal-title":"Neurobiol Dis"},{"issue":"7","key":"10.1053\/j.semperi.2015.03.006_bib26","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","article-title":"A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2","volume":"8","author":"Monani","year":"1999","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1053\/j.semperi.2015.03.006_bib27","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1086\/302372","article-title":"The promoters of the survival motor neuron gene (SMN) and its copy (SMNc) share common regulatory elements","volume":"64","author":"Echaniz-Laguna","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1053\/j.semperi.2015.03.006_bib28","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"Lorson","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1053\/j.semperi.2015.03.006_bib29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng854","article-title":"Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1","volume":"30","author":"Cartegni","year":"2002","journal-title":"Nat Genet"},{"issue":"1","key":"10.1053\/j.semperi.2015.03.006_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ng0598-63","article-title":"SMN oligomerization defect correlates with spinal muscular atrophy severity","volume":"19","author":"Lorson","year":"1998","journal-title":"Nat Genet"},{"issue":"8","key":"10.1053\/j.semperi.2015.03.006_bib31","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1177\/0883073807305787","article-title":"Molecular mechanisms of spinal muscular atrophy","volume":"22","author":"Sumner","year":"2007","journal-title":"J Child Neurol"},{"issue":"18","key":"10.1053\/j.semperi.2015.03.006_bib32","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1073\/pnas.94.18.9920","article-title":"Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos","volume":"94","author":"Schrank","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1053\/j.semperi.2015.03.006_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","article-title":"A mouse model for spinal muscular atrophy","volume":"24","author":"Hsieh-Li","year":"2000","journal-title":"Nat Genet"},{"issue":"3","key":"10.1053\/j.semperi.2015.03.006_bib34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","article-title":"The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(\u2212\/\u2212) mice and results in a mouse with spinal muscular atrophy","volume":"9","author":"Monani","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1053\/j.semperi.2015.03.006_bib35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/513886","article-title":"Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype","volume":"61","author":"Campbell","year":"1997","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1053\/j.semperi.2015.03.006_bib36","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/515465","article-title":"Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number","volume":"60","author":"McAndrew","year":"1997","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1053\/j.semperi.2015.03.006_bib37","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","volume":"70","author":"Feldkotter","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1053\/j.semperi.2015.03.006_bib38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ajmg.a.30251","article-title":"Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2","volume":"130a","author":"Prior","year":"2004","journal-title":"Am J Med Genet A"},{"issue":"7","key":"10.1053\/j.semperi.2015.03.006_bib39","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/emmm.201202305","article-title":"Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compounds","volume":"5","author":"Cherry","year":"2013","journal-title":"EMBO Mol Med"},{"issue":"3","key":"10.1053\/j.semperi.2015.03.006_bib40","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2009.08.002","article-title":"A positive modifier of spinal muscular atrophy in the SMN2 gene","volume":"85","author":"Prior","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1053\/j.semperi.2015.03.006_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng0797-265","article-title":"Correlation between severity and SMN protein level in spinal muscular atrophy","volume":"16","author":"Lefebvre","year":"1997","journal-title":"Nat Genet"},{"issue":"8","key":"10.1053\/j.semperi.2015.03.006_bib42","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","article-title":"The survival motor neuron protein in spinal muscular atrophy","volume":"6","author":"Coovert","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"5599","key":"10.1053\/j.semperi.2015.03.006_bib43","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1126\/science.1074962","article-title":"Essential role for the SMN complex in the specificity of snRNP assembly","volume":"298","author":"Pellizzoni","year":"2002","journal-title":"Science"},{"issue":"6","key":"10.1053\/j.semperi.2015.03.006_bib44","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0092-8674(00)80368-2","article-title":"The SMN\u2013SIP1 complex has an essential role in spliceosomal snRNP biogenesis","volume":"90","author":"Fischer","year":"1997","journal-title":"Cell"},{"issue":"6","key":"10.1053\/j.semperi.2015.03.006_bib45","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0092-8674(00)80367-0","article-title":"The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins","volume":"90","author":"Liu","year":"1997","journal-title":"Cell"},{"issue":"13","key":"10.1053\/j.semperi.2015.03.006_bib46","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/hmg\/9.13.1977","article-title":"Characterization of a nuclear 20S complex containing the survival of motor neurons (SMN) protein and a specific subset of spliceosomal Sm proteins","volume":"9","author":"Meister","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1053\/j.semperi.2015.03.006_bib47","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1074\/jbc.M608528200","article-title":"A comprehensive interaction map of the human survival of motor neuron (SMN) complex","volume":"282","author":"Otter","year":"2007","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1053\/j.semperi.2015.03.006_bib48","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1083\/jcb.200304128","article-title":"Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons","volume":"163","author":"Rossoll","year":"2003","journal-title":"J Cell Biol"},{"issue":"16","key":"10.1053\/j.semperi.2015.03.006_bib49","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1523\/JNEUROSCI.23-16-06627.2003","article-title":"Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization","volume":"23","author":"Zhang","year":"2003","journal-title":"J Neurosci"},{"issue":"24","key":"10.1053\/j.semperi.2015.03.006_bib50","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1093\/hmg\/ddr425","article-title":"The spinal muscular atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin","volume":"20","author":"Nolle","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1053\/j.semperi.2015.03.006_bib51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mcn.2009.05.009","article-title":"SMN, profilin IIa and plastin 3: a link between the deregulation of actin dynamics and SMA pathogenesis","volume":"42","author":"Bowerman","year":"2009","journal-title":"Mol Cel Neurosci"},{"issue":"1","key":"10.1053\/j.semperi.2015.03.006_bib52","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.nmd.2007.09.001","article-title":"Other forms of survival motor neuron protein and spinal muscular atrophy: an opinion","volume":"18","author":"Burghes","year":"2008","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1053\/j.semperi.2015.03.006_bib53","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s13311-014-0293-y","article-title":"Spinal muscular atrophy: journeying from bench to bedside","volume":"11","author":"Awano","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"20","key":"10.1053\/j.semperi.2015.03.006_bib54","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.wnl.0000290830.40544.b9","article-title":"The changing natural history of spinal muscular atrophy type 1","volume":"69","author":"Oskoui","year":"2007","journal-title":"Neurology"},{"issue":"8","key":"10.1053\/j.semperi.2015.03.006_bib55","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/0883073807305788","article-title":"Consensus statement for standard of care in spinal muscular atrophy","volume":"22","author":"Wang","year":"2007","journal-title":"J Child Neurol"},{"issue":"2","key":"10.1053\/j.semperi.2015.03.006_bib56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.24316","article-title":"Cystic fibrosis newborn screening: a model for neuromuscular disease screening?","volume":"77","author":"Scully","year":"2015","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1053\/j.semperi.2015.03.006_bib57","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11910-004-0016-6","article-title":"Spinal muscular atrophy","volume":"4","author":"Iannaccone","year":"2004","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1053\/j.semperi.2015.03.006_bib58","unstructured":"SMA Drug Pipeline. \u3008http:\/\/www.curesma.org\/documents\/research-documents\/oct-2014-drug-pipeline.pdf\u3009; Accessed 11.15.14."},{"issue":"8","key":"10.1053\/j.semperi.2015.03.006_bib59","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1261\/rna.7580704","article-title":"In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes","volume":"10","author":"Singh","year":"2004","journal-title":"RNA"},{"issue":"7367","key":"10.1053\/j.semperi.2015.03.006_bib60","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model","volume":"478","author":"Hua","year":"2011","journal-title":"Nature"},{"issue":"72","key":"10.1053\/j.semperi.2015.03.006_bib61","doi-asserted-by":"crossref","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","article-title":"Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy","volume":"3","author":"Passini","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1053\/j.semperi.2015.03.006_bib62","doi-asserted-by":"crossref","unstructured":"Chirboga CSK, Darras B, Iannaccone S, et al. Results of an open-label, escalating dose study to assess the safety, tolerability, and dose range finding of a single intrathecal dose of ISIS-SMNRx in patients with spinal muscular atrophy. Paper presented in: 65th American Academy of Neurology Annual Meeting; 16\u201323 March 2013; San Diego, CA. Vol 80, ppS S36.002, American Academy of Neurology, Minneapolis, MN.","DOI":"10.1212\/WNL.80.7_supplement.S36.002"},{"issue":"R1","key":"10.1053\/j.semperi.2015.03.006_bib63","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1093\/hmg\/ddq147","article-title":"Spinal muscular atrophy: mechanisms and therapeutic strategies","volume":"19","author":"Lorson","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1053\/j.semperi.2015.03.006_bib64","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00109-008-0388-1","article-title":"Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice","volume":"86","author":"Tsai","year":"2008","journal-title":"J Mol Med"},{"issue":"5","key":"10.1053\/j.semperi.2015.03.006_bib65","doi-asserted-by":"crossref","first-page":"5ra12","DOI":"10.1126\/scitranslmed.3000208","article-title":"Tetracyclines that promote SMN2 exon 7 splicing as therapeutics for spinal muscular atrophy","volume":"1","author":"Hastings","year":"2009","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1053\/j.semperi.2015.03.006_bib66","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1172\/JCI29562","article-title":"Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy","volume":"117","author":"Avila","year":"2007","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1053\/j.semperi.2015.03.006_bib67","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.21449","article-title":"Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition","volume":"64","author":"Narver","year":"2008","journal-title":"Ann Neurol"},{"issue":"19","key":"10.1053\/j.semperi.2015.03.006_bib68","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1093\/hmg\/ddp313","article-title":"LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate","volume":"18","author":"Garbes","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1053\/j.semperi.2015.03.006_bib69","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/hmg\/ddq023","article-title":"SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy","volume":"19","author":"Riessland","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"20","key":"10.1053\/j.semperi.2015.03.006_bib70","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1093\/hmg\/ddp333","article-title":"Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model","volume":"18","author":"Mattis","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1053\/j.semperi.2015.03.006_bib71","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.nurt.2008.08.007","article-title":"Spinal muscular atrophy","volume":"5","author":"Oskoui","year":"2008","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1053\/j.semperi.2015.03.006_bib72","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/01.wnl.0000249142.82285.d6","article-title":"Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy","volume":"68","author":"Mercuri","year":"2007","journal-title":"Neurology"},{"issue":"5","key":"10.1053\/j.semperi.2015.03.006_bib73","doi-asserted-by":"crossref","first-page":"e5268","DOI":"10.1371\/journal.pone.0005268","article-title":"Phase II open label study of valproic acid in spinal muscular atrophy","volume":"4","author":"Swoboda","year":"2009","journal-title":"PloS One"},{"key":"10.1053\/j.semperi.2015.03.006_bib74","unstructured":"Efficacy of Riluzole in Children and Young Adults. \u3008https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00774423\u3009; Accessed 01.15.15."},{"issue":"2","key":"10.1053\/j.semperi.2015.03.006_bib75","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/jpet.107.123000","article-title":"Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis","volume":"322","author":"Bordet","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1053\/j.semperi.2015.03.006_bib76","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1261\/rna.1008208","article-title":"DcpS scavenger decapping enzyme can modulate pre-mRNA splicing","volume":"14","author":"Shen","year":"2008","journal-title":"RNA"},{"issue":"6","key":"10.1053\/j.semperi.2015.03.006_bib77","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1517\/14712598.2012.681463","article-title":"The advent of AAV9 expands applications for brain and spinal cord gene delivery","volume":"12","author":"Dayton","year":"2012","journal-title":"Expert Opin Biol Ther"},{"issue":"35","key":"10.1053\/j.semperi.2015.03.006_bib78","doi-asserted-by":"crossref","first-page":"35ra42","DOI":"10.1126\/scitranslmed.3000830","article-title":"Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy","volume":"2","author":"Valori","year":"2010","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1053\/j.semperi.2015.03.006_bib79","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.bbadis.2013.08.005","article-title":"Spinal muscular atrophy: an update on therapeutic progress","volume":"1832","author":"Seo","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"10.1053\/j.semperi.2015.03.006_bib80","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/mt.2009.71","article-title":"Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons","volume":"17","author":"Duque","year":"2009","journal-title":"Mol Ther"},{"issue":"1","key":"10.1053\/j.semperi.2015.03.006_bib81","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1053\/j.semperi.2015.03.006_bib82","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/mt.2011.72","article-title":"Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates","volume":"19","author":"Gray","year":"2011","journal-title":"Mol Ther"},{"issue":"4","key":"10.1053\/j.semperi.2015.03.006_bib83","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI41615","article-title":"CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy","volume":"120","author":"Passini","year":"2010","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1053\/j.semperi.2015.03.006_bib84","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1089\/hum.2011.008","article-title":"Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery","volume":"22","author":"Snyder","year":"2011","journal-title":"Hum Gene Ther"},{"issue":"8","key":"10.1053\/j.semperi.2015.03.006_bib85","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/gt.2011.130","article-title":"Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs","volume":"19","author":"Federici","year":"2012","journal-title":"Gene Ther"},{"issue":"8","key":"10.1053\/j.semperi.2015.03.006_bib86","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/0883073807305672","article-title":"Spinal muscular atrophy genetic counseling access and genetic knowledge: parents\u2019 perspectives","volume":"22","author":"Meldrum","year":"2007","journal-title":"J Child Neurol"},{"issue":"11","key":"10.1053\/j.semperi.2015.03.006_bib87","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/mt.2011.157","article-title":"Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders","volume":"19","author":"Bevan","year":"2011","journal-title":"Mol Ther"},{"issue":"8","key":"10.1053\/j.semperi.2015.03.006_bib88","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1172\/JCI57291","article-title":"Postsymptomatic restoration of SMN rescues the disease phenotype in a mouse model of severe spinal muscular atrophy","volume":"121","author":"Lutz","year":"2011","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1053\/j.semperi.2015.03.006_bib89","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.23995","article-title":"Spinal muscular atrophy: development and implementation of potential treatments","volume":"74","author":"Arnold","year":"2013","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1053\/j.semperi.2015.03.006_bib90","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"4","key":"10.1053\/j.semperi.2015.03.006_bib91","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1242\/dmm.007245","article-title":"The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy","volume":"4","author":"Sleigh","year":"2011","journal-title":"Dis Model Mech"},{"issue":"12","key":"10.1053\/j.semperi.2015.03.006_bib92","doi-asserted-by":"crossref","first-page":"e15887","DOI":"10.1371\/journal.pone.0015887","article-title":"Mouse survival motor neuron alleles that mimic SMN2 splicing and are inducible rescue embryonic lethality early in development but not late","volume":"5","author":"Hammond","year":"2010","journal-title":"PloS One"},{"issue":"2","key":"10.1053\/j.semperi.2015.03.006_bib93","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1440-1681.1999.02987.x","article-title":"Barrier mechanisms in the brain, II. Immature brain","volume":"26","author":"Saunders","year":"1999","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"7","key":"10.1053\/j.semperi.2015.03.006_bib94","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1111\/j.1460-9568.2007.05780.x","article-title":"Cell therapy and stem cells in animal models of motor neuron disorders","volume":"26","author":"Hedlund","year":"2007","journal-title":"Eur J Neurosci"},{"issue":"2","key":"10.1053\/j.semperi.2015.03.006_bib95","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1517\/14712598.8.2.137","article-title":"Human stem cell grafts as therapies for motor neuron disease","volume":"8","author":"Koliatsos","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"10.1053\/j.semperi.2015.03.006_bib96","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tins.2008.01.006","article-title":"Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis","volume":"31","author":"Suzuki","year":"2008","journal-title":"Trends Neurosci"},{"issue":"10","key":"10.1053\/j.semperi.2015.03.006_bib97","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1172\/JCI35432","article-title":"Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy","volume":"118","author":"Corti","year":"2008","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1053\/j.semperi.2015.03.006_bib98","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/75705","article-title":"Cell replacement therapies for central nervous system disorders","volume":"3","author":"Bjorklund","year":"2000","journal-title":"Nat Neurosci"},{"issue":"3","key":"10.1053\/j.semperi.2015.03.006_bib99","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0092-8674(02)00835-8","article-title":"Directed differentiation of embryonic stem cells into motor neurons","volume":"110","author":"Wichterle","year":"2002","journal-title":"Cell"},{"issue":"2","key":"10.1053\/j.semperi.2015.03.006_bib100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nbt1063","article-title":"Specification of motoneurons from human embryonic stem cells","volume":"23","author":"Li","year":"2005","journal-title":"Nat Biotechnol"},{"issue":"5893","key":"10.1053\/j.semperi.2015.03.006_bib101","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1158799","article-title":"Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons","volume":"321","author":"Dimos","year":"2008","journal-title":"Science"},{"key":"10.1053\/j.semperi.2015.03.006_bib102","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/brain\/awp318","article-title":"Embryonic stem cell-derived neural stem cells improve spinal muscular atrophy phenotype in mice","volume":"Pt 2","author":"Corti","year":"2010","journal-title":"Brain"},{"issue":"3","key":"10.1053\/j.semperi.2015.03.006_bib103","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ana.24113","article-title":"Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes","volume":"75","author":"Feldman","year":"2014","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1053\/j.semperi.2015.03.006_bib104","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.20473","article-title":"Natural history of denervation in SMA: relation to age, SMN2 copy number, and function","volume":"57","author":"Swoboda","year":"2005","journal-title":"Ann Neurol"},{"issue":"21","key":"10.1053\/j.semperi.2015.03.006_bib105","first-page":"390","article-title":"CDC Grand Rounds: newborn screening and improved outcomes","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8955","key":"10.1053\/j.semperi.2015.03.006_bib106","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(95)90732-7","article-title":"PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy","volume":"345","author":"van der Steege","year":"1995","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.semperi.2015.03.006_bib107","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajmg.10744","article-title":"Rapid SMN1 deletion test using DHPLC to screen patients with spinal muscular atrophy","volume":"113","author":"Sutomo","year":"2002","journal-title":"Am J Med Genet"},{"issue":"5","key":"10.1053\/j.semperi.2015.03.006_bib108","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s00415-006-0410-x","article-title":"A novel mutation at the N-terminal of SMN Tudor domain inhibits its interaction with target proteins","volume":"254","author":"Kotani","year":"2007","journal-title":"J Neurol"},{"issue":"5","key":"10.1053\/j.semperi.2015.03.006_bib109","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/humu.20160","article-title":"Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a highly efficient and reliable carrier-screening test","volume":"25","author":"Su","year":"2005","journal-title":"Hum Mutat"},{"issue":"12","key":"10.1053\/j.semperi.2015.03.006_bib110","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.nmd.2006.08.011","article-title":"Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy","volume":"16","author":"Arkblad","year":"2006","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1053\/j.semperi.2015.03.006_bib111","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.mcp.2010.07.001","article-title":"Quick MLPA test for quantification of SMN1 and SMN2 copy numbers","volume":"24","author":"Passon","year":"2010","journal-title":"Mol Cell Probes"},{"issue":"2","key":"10.1053\/j.semperi.2015.03.006_bib112","doi-asserted-by":"crossref","first-page":"e17067","DOI":"10.1371\/journal.pone.0017067","article-title":"Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study","volume":"6","author":"Su","year":"2011","journal-title":"PloS One"},{"issue":"5","key":"10.1053\/j.semperi.2015.03.006_bib113","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/(SICI)1096-8628(19990827)85:5<463::AID-AJMG6>3.0.CO;2-V","article-title":"Duplications and de novo deletions of the SMNt gene demonstrated by fluorescence-based carrier testing for spinal muscular atrophy","volume":"85","author":"Chen","year":"1999","journal-title":"Am J Med Genet"},{"issue":"5","key":"10.1053\/j.semperi.2015.03.006_bib114","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1086\/302369","article-title":"Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype\u2013phenotype correlation, and implications for genetic counseling","volume":"64","author":"Wirth","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1053\/j.semperi.2015.03.006_bib115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.ejhg.5200404","article-title":"SMA carrier testing\u2014validation of hemizygous SMN exon 7 deletion test for the identification of proximal spinal muscular atrophy carriers and patients with a single allele deletion","volume":"8","author":"Scheffer","year":"2000","journal-title":"Eur J Hum Genet"},{"issue":"13","key":"10.1053\/j.semperi.2015.03.006_bib116","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1039\/c1lc20126c","article-title":"Multiplex digital PCR: breaking the one target per color barrier of quantitative PCR","volume":"11","author":"Zhong","year":"2011","journal-title":"Lab Chip"},{"issue":"5","key":"10.1053\/j.semperi.2015.03.006_bib117","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1039\/c3lc50980j","article-title":"Lab-on-a-chip technology: impacting non-invasive prenatal diagnostics (NIPD) through miniaturisation","volume":"14","author":"Kantak","year":"2014","journal-title":"Lab Chip"},{"key":"10.1053\/j.semperi.2015.03.006_bib118","unstructured":"Taylor ddPCR Cambridge Digital PCR Meeting. http:\/\/www.healthtech.com\/Conferences_Overview.aspx?id=138531&libID=138502; Accessed 01.09.15."},{"key":"10.1053\/j.semperi.2015.03.006_bib119","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2350-10-45","article-title":"Rapid diagnosis of spinal muscular atrophy using high-resolution melting analysis","volume":"10","author":"Chen","year":"2009","journal-title":"BMC Med Genet"},{"issue":"10","key":"10.1053\/j.semperi.2015.03.006_bib120","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/gtmb.2010.0237","article-title":"Diagnosis of spinal muscular atrophy via high-resolution melting analysis symmetric polymerase chain reaction without probe: a screening evaluation for SMN1 deletions and intragenic mutations","volume":"15","author":"Morikawa","year":"2011","journal-title":"Genet Test Mol Biomarkers"},{"issue":"6","key":"10.1053\/j.semperi.2015.03.006_bib121","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/humu.10144","article-title":"Implementation of SMA carrier testing in genetic laboratories: comparison of two methods for quantifying the SMN1 gene","volume":"20","author":"Cusco","year":"2002","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1053\/j.semperi.2015.03.006_bib122","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10048-007-0093-1","article-title":"Robust quantification of the SMN gene copy number by real-time TaqMan PCR","volume":"8","author":"Gomez-Curet","year":"2007","journal-title":"Neurogenetics"},{"issue":"3","key":"10.1053\/j.semperi.2015.03.006_bib123","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1442-200X.2008.02590.x","article-title":"SMN2 and NAIP gene dosages in Vietnamese patients with spinal muscular atrophy","volume":"50","author":"Tran","year":"2008","journal-title":"Pediatr Int"},{"issue":"3","key":"10.1053\/j.semperi.2015.03.006_bib124","first-page":"188","article-title":"Gene dosage analysis of proximal spinal muscular atrophy carriers using real-time PCR","volume":"14","author":"Abbaszadegan","year":"2011","journal-title":"Arch Iran Med"},{"issue":"1\u20132","key":"10.1053\/j.semperi.2015.03.006_bib125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.clinbiochem.2011.10.019","article-title":"Spinal muscular atrophy: clinical validation of a single-tube multiplex real time PCR assay for determination of SMN1 and SMN2 copy numbers","volume":"45","author":"Maranda","year":"2012","journal-title":"Clin Biochem"},{"issue":"5","key":"10.1053\/j.semperi.2015.03.006_bib126","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1086\/301608","article-title":"De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling","volume":"61","author":"Wirth","year":"1997","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1053\/j.semperi.2015.03.006_bib127","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/GIM.0b013e3181d2af04","article-title":"Committee report: method for evaluating conditions nominated for population-based screening of newborns and children","volume":"12","author":"Calonge","year":"2010","journal-title":"Genet Medi"},{"issue":"2","key":"10.1053\/j.semperi.2015.03.006_bib128","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1053\/j.semperi.2009.12.003","article-title":"Improving and assuring newborn screening laboratory quality worldwide: 30-year experience at the Centers for Disease Control and Prevention","volume":"34","author":"De Jesus","year":"2010","journal-title":"Semin Perinatol"},{"issue":"4","key":"10.1053\/j.semperi.2015.03.006_bib129","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1751-553X.2007.00854.x","article-title":"Application of flow cytometry-based genotyping for rapid detection of hemoglobin variants","volume":"29","author":"Aslanian","year":"2007","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"10.1053\/j.semperi.2015.03.006_bib130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1373\/clinchem.2009.132480","article-title":"Newborn screening for cystic fibrosis by use of a multiplex immunoassay","volume":"56","author":"Lindau-Shepard","year":"2010","journal-title":"Clin Chem"},{"key":"10.1053\/j.semperi.2015.03.006_bib131","unstructured":"JI Miller, JR Botkin, E Lyon, et al. Feasibility of a Population Based Newborn Screening Study for Spinal Muscular Atrophy in Colorado. \u3008http:\/\/www.aphl.org\/conferences\/proceedings\/Documents\/2014\/NBS\/38Miller.pdf\u3009; Accessed 12.10.14."},{"issue":"3","key":"10.1053\/j.semperi.2015.03.006_bib132","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","article-title":"An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA)","volume":"15","author":"Wirth","year":"2000","journal-title":"Hum Mutat"},{"issue":"42","key":"10.1053\/j.semperi.2015.03.006_bib133","doi-asserted-by":"crossref","first-page":"13233","DOI":"10.1021\/bi0485732","article-title":"LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA","volume":"43","author":"Vester","year":"2004","journal-title":"Biochemistry"},{"issue":"4","key":"10.1053\/j.semperi.2015.03.006_bib134","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ajmg.a.35756","article-title":"Public attitudes regarding a pilot study of newborn screening for spinal muscular atrophy","volume":"161a","author":"Rothwell","year":"2013","journal-title":"Am J Med Genet A"},{"issue":"6","key":"10.1053\/j.semperi.2015.03.006_bib135","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/mus.24100","article-title":"Parental attitudes toward newborn screening for Duchenne\/Becker muscular dystrophy and spinal muscular atrophy","volume":"49","author":"Wood","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1053\/j.semperi.2015.03.006_bib136","unstructured":"Advisory Committee on Heritable Disorders in Newborns and Children. \u3008http:\/\/www.hrsa.gov\/advisorycommittees\/mchbadvisory\/heritabledisorders\/nominatecondition\/reviews\/spinalmuscleatrophydecision.pdf\u3009; Accessed 02.20.15."},{"key":"10.1053\/j.semperi.2015.03.006_bib137","unstructured":"Feasibility of Newborn Screening for Spinal Muscular Atrophy. \u3008http:\/\/submissions.mirasmart.com\/ACMG\/Browse.aspx?colID=7\u3009; Accessed 02.20.15."},{"issue":"1","key":"10.1053\/j.semperi.2015.03.006_bib138","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/humu.10221","article-title":"Determination of SMN1 and SMN2 copy number using TaqMan technology","volume":"22","author":"Anhuf","year":"2003","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1053\/j.semperi.2015.03.006_bib139","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10048-006-0051-3","article-title":"Spinal muscular atrophy genotyping by gene dosage using multiple ligation-dependent probe amplification","volume":"7","author":"Scarciolla","year":"2006","journal-title":"Neurogenetics"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000515000233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000515000233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T19:18:10Z","timestamp":1717874290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000515000233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":139,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0146000515000233"],"URL":"https:\/\/doi.org\/10.1053\/j.semperi.2015.03.006","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newborn screening for spinal muscular atrophy: Anticipating an imminent need","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semperi.2015.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}